✦ LIBER ✦

New drug approval times and clinical evidence in Japan

✍ Scribed by Shunsuke Ono; Chisato Yoshioka; Orie Asaka; Koji Tamura; Taro Shibata; Kazuyuki Saito

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical data packages of drug approval

✍ Sakushima, K.; Nakamura, H.; Hashizume, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Representation of older patients in clin

✍ Asahina, Yasuko; Sugano, H.; Sugiyama, E.; Uyama, Y. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 144 KB

Clinical Development and Review Times fo

✍ Ishibashi, T; Yasuda, K; Kusama, M; Sugiyama, Y; Ono, S 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Recent Trends and Success Factors in Red

✍ Honig, P K 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 201 KB

Clinically relevant end points and new d

✍ Anderson, K C; Kyle, R A; Rajkumar, S V; Stewart, A K; Weber, D; Richardson, P 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

Targeted Regulatory Writing Techniques:

✍ Wood, Linda Fossati; Foote, MaryAnn 📂 Article 📅 2009 🏛 Birkhäuser Basel ⚖ 199 KB